Mergers & Acquisitions
Jul. 8, 2003
Pharmaceutical Firms Will Join Forces
In another massive biotechnology deal, Biogen Inc. and Idec Pharmaceuticals Corp. have agreed to merge in a multibillion-dollar stock swap.
The deal was valued at $6.4 billion when it was announced in June, making it the largest biotech deal since the $17.7 billion merger of Amgen Inc. and Immunex Corp. that closed ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In